Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Ortho Regenerative Technologies (ORTIF)

Ortho Regenerative Technologies (ORTIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX PR Newswire - Wed Sep 7, 2022

/PRNewswire/ - Ortho Regenerative Technologies Inc., (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company") a clinical-stage orthobiologics company focused on...

ORTIF : 0.1962 (-7.50%)
ORTH.CN : 0.250 (unch)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX Newswire.ca - Wed Sep 7, 2022

/CNW Telbec/ - Ortho Regenerative Technologies Inc., (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company") a clinical-stage orthobiologics company focused on...

CHGX.CN : 0.0650 (unch)
ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Newswire.ca - Wed Jul 27, 2022

/CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL PR Newswire - Wed Jul 27, 2022

/PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS Newswire.ca - Fri Jul 22, 2022

/CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTS Newswire.ca - Fri Jun 24, 2022

Patients recruitment initiated for U.S. Phase I/II rotator cuff tear repair clinical trial in June 2023 Philippe Deschamps appointed as new CEO Signing of...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL PR Newswire - Mon Jun 13, 2022

/PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Newswire.ca - Mon Jun 13, 2022

/CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on the...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR Newswire.ca - Thu May 26, 2022

/CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on the...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTS Newswire.ca - Fri May 20, 2022

Phase I/II clinical trial IND application cleared by FDA for testing ORTHO-R in combination with PRP for rotator cuff tear repair ORTHO-R / PRP combination...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)

Barchart Exclusives

3 Highest-Yielding (And Safest) Dividend Aristocrats To Buy Today Barchart - Fri Apr 26, 6:30PM CDT
The highest-yielding dividend aristocrats aren't always the safest stocks to buy. Here's what I did to counteract this. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot